Biovica appoints Maria Ekdahl CFO
Analysis based on 6 articles · First reported Jul 07, 2026 · Last updated Jul 07, 2026
The appointment is a routine executive change with limited market impact. Biovica's stock fell 9.71% on the announcement day, but this may reflect broader market conditions rather than the appointment itself.
Biovica International AB announced the appointment of Maria Ekdahl as Chief Financial Officer, effective October 14, 2026. Ekdahl brings over 20 years of senior finance leadership experience, including her current role as CFO of Infant Bacterial Therapeutics AB. She will succeed Anders Mortensen. The appointment is part of Biovica's scaling of its US-focused commercial strategy.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard